EirGenix

EirGenix Goodwill

Goodwill of EirGenix (6589.TWO) as of Oct 21, 2026.

Goodwill

-TWD

Last updated:

Goodwill of EirGenix is 2026 - TWD. Goodwill of EirGenix was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EirGenix Stock analysis

What does EirGenix do? EirGenix Inc. generates revenue through its Contract Development & Manufacturing Organization (CDMO) services, which include the construction of cell strains, manufacturing of clinical trial medicines, and analytical science and protein identification. The company operates a PIC/S manufacturing plant dedicated to producing clinical trial drugs for pharmaceutical clients. Its primary customers are pharmaceutical companies seeking outsourced development and manufacturing solutions for biotechnology drugs. The business segments focus on providing end-to-end services from research and development to clinical trial production, targeting the biotechnology and pharmaceutical sectors. EirGenix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EirGenix stock

On Eulerpool you can find the complete historical development of Goodwill EirGenix since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's EirGenix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — EirGenix

All Key Metrics — EirGenix